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Bioluminescent Methods for Determining Metabolites in Micro-Samples
of Pig Plasma1)
Melinda J. Thompson, Peter G. Arthur and Peter E. Hartmann
Department of Biochemistry, The University of Western Australia, Neulands, Australia
Summary: A highly sensitive and simplified method for the luminometric determination of plasma metabolites has
been developed. Furthermore, the technique has been automated for the Dynatech ML2250 Microtiter Plate Lurnino-
meter and can be applied to the measurement of any plasma metabolite which may be coupled to a reaction
involving the reduction of NAD+. Assays are described for lactose/galactose, -hydroxybutyrate and £>-lactate, and
have been validated with plasma samples. The assays require 1 — 2 μΐ of plasma, and are capable of detecting
concentrations below 5 μηιοΐ/ΐ. Since luminometry is based on the kinetics of the luciferase/oxidoreductase enzyme
system, components of complex biological samples may interfere with the rate of the reaction; necessitating the
use of internal standards for individual samples. However, the need for internal standards to account for sample to
sample variation in the luminescent response, has been eliminated with the present technique.
Introduction
Luminometry involving bacterial luciferase2) is based
on the production of light during a two stage reaction
catalyzed by luciferase and NAD(P)H:FMN oxidoreduc-
tase2), and requiring reduced nicotinamide adenine dinu-
cleotide (NADH), flavin mononucleotide (FMN), a long
chain aldehyde and molecular oxygen. When all other
substrates are present in excess, the rate of light pro-
duction is dependent upon the concentration of NADH.
Thus, pre-existing assays involving the production of
NAD(P)H may be coupled to a luminescent reaction,
providing greater sensitivity than can be obtained in
either a spectrophotometer or fluorometer (1—2).
Recent advances in bioluminescent assays (1—3) have
decreased the volume of sample required for the analysis
of multiple metabolites. This allows frequent blood sam-
pling from small animals without a significant reduction
in blood volume. Furthermore, it is often advantageous
to collect finger-prick blood samples from humans.
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2) Enzymes:
Galactose dehydrogenase:
D-Galactose : NAD+ 1-oxidoreductase (EC 1.1.1.48);
-Galactosidase:
-Z)-Galactoside galactohydrolase (EC 3.2.1.23);
Hydroxybutyrate dehydrogenase:
[R]-3-Hydroxybutanoate : NAD+ oxidoreductase
(EC 1.1.1.30);
D-Lactate dehydrogenase:
[R]-Lactate : NAD+ oxidoreductase (EC 1.1.1.28);
Luciferase:
Alkanal: reduced-FMN-oxygen oxidoreductase (EC 1.14.13.3);
Oxidoreductase:
NAD(P)H : FMN oxidoreductase (EC 1.6.8.1).
However, the usefulness of bioluminescence as an ana-
lytical tool has been hindered by the expense and limited
stability of the reagent (1). Furthermore, previously de-
scribed bioluminescent assays have presented measure-
ments either from standards and not biological samples,
or have required internal standards to account for the
interference from the samples (2, 4, 5).
We have developed a semi-automatic procedure which
allows the rapid measurement of any plasma metabolite
which can be coupled to a NADH-producing reaction.
In addition to decreasing the cost of the assays, and
increasing the stability of the reagents, the sensitivity of
the technique described here has allowed large dilution
of the sample, thus removing sample-specific inhibition
of the kinetic, bioluminescent reaction.
The assays described here were chosen for their possible
clinical significance. Plasma lactose may provide an in-
dication of gastrointestinal disorders associated with
increased gut permeability (6), while increases in the
plasma concentration of -hydroxybutyrate and D-lac-




All reagents were prepared from analytical grade chemicals and
were dissolved in de-ionized water.
Bioluminescent reagent
The first step in the assays was the metabolite-specific reaction
resulting in the production of NADH; the reagents for which are
described below. However, the measurement of the NADH through
the bioluminescent reaction was common to all the assays and the
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reagent was prepared as described by Arthur & Hochachka (3)
with the following modifications. The reagent contained potassium
phosphate (100 mmol/1), bovine serum albumin (essentially fatty
acid free; 16 g/1), EDTA (disodium salt; 4 mmol/1), FMN
(8 μηιοΐ/l), tetradecanal (Aldrich Chemical Co., NY: 1 g/1) and lu-
ciferase2) (Sigma Chemical Co.: EC 1.14.14.3: protein 0.2 g/1) in
tris[hydroxymethyl]methyl-2-aminoethanesulphonic acid (TES)
buffer (300 mmol/1, pH 6.8) and was aliquoted and frozen at
-80 °C. The reagent was stable for at least four months if stored
at —80 °C and protected from light. The addition of a second en-
zyme was not required since the luciferase preparation was con-
taminated with oxidoreductase. The light response obtained was
similar to previous experiments (1, 3) which used pure enzyme
preparations of luciferase (6 mg/1 final reaction volume) and oxi-
doreductase (33 U/l final reaction volume), however, the impure
Sigma preparation represented a significant reduction in cost.
Reagents for metabolite assays
The -hydroxybutyrate assay was based on the conversion of -
hydroxybutyrate to acetoacetate by hydroxybutyrate dehydroge-
nase2) (Boehringer Mannheim, North Ryde, Australia: EC
1.1.1.30), with the co-production of NADH. The assay was adapted
from an existing spectrophotometric iron-chelate assay (7). Since
the equilibrium for -hydroxybutyrate dehydrogenase is unfavour-
able for acetoacetate formation (8), the reaction was driven with
hydrazine. Reagent A for -hydroxybutyrate, containing hydrazine
sulphate (50 umol/1), NAD+ (250 umol/1), and hydroxybutyrate
dehydrogenase (40 U/l) in TES buffer (0.1 mol/1, pH 8.4), was
prepared fresh for each sample set. The ammonium sulphate sus-
pension of hydroxybutyrate dehydrogenase was unsuitable for long
term storage of the enzyme. However, resuspension in a buffer
containing calcium chloride (1 mmol/1) in potassium phosphate (10
mmol/1; pH 7) allowed storage of the enzyme at -20 °C (9), and
decreased the background readings.
The D-lactate assay was a modification of an existing fluorometric
assay (10) involving conversion by Z)-lactate dehydrogenase2)
(Sigma Chemical Col, Missouri, USA: EC 1.1.1.28). Reagent A
for D-lactate was prepared fresh and contained hydrazine sulphate
(5 mmol/1), ascorbic acid (2 mmol/1), NAD+ (2 mmol/1) and D-
lactate dehydrogenase (51 kU/1) in glycine buffer (l mol/1, pH 9).
A spectrophotometric assay for the determination of galactose (11)
was modified for the measurement of lactose on the luminometer.
Lactose was hydrolyzed by -galactosidase2) (Boehringer Mann-
heim: EC 3.2.1.23) and the galactose moiety reacted in the pres-
ence of galactose dehydrogenase2) (Boehringer Mannheim: EC
1.1.1.48). The reagents for the measurement of lactose could be
prepared in advance, were stable, and showed no increase in back-
ground readings, if stored on ice for 24 hours. Lactose reagent A
(for hydrolysis of lactose) contained MgCl2 (1.9 mmol/1) and -
galactosidase (3 kU/1) in potassium phosphate buffer (85 mmol/1,
pH 8), while reagent B (for oxidation of galactose) contained
MgCl2 (1.9 mmol/1), NAD+ (2.9 mmol/1) and galactose dehydroge-
nase (1.2 kU/1) in potassium phosphate buffer (85 mmol/1, pH 8).
Apparatus
Working standards were checked on a Titertek Multiskan® MCC/
340 plate reader (Flow Laboratories, McLean, VA, USA). Other-
wise a Dynatech ML2250 Microtiter Plate Luminometer (Dynex,
Chantilly, VA, USA) was used.
Plasma samples
Blood samples (60 μΐ) were taken from the ear vein of 11 Landrace
and Large White (pure and cross-breed) piglets according to the
method of Holmes et al. (11). Plasma was separated by centrifuga-
tion at 3000 g for 5 minutes, deproteinized with perchloric acid
(0.6 mol/1) and neutralized according to the method of Arthur et
al. (1), and buffered (0.1 mol/1; pH « 7) with either glycine (D-
lactate assay) or phosphate ( -hydroxybutyrate and lactose) before
being stored at —20 °C. Blanks consisting of de-ionized water,
standards, and plasma samples used as quality controls, were also
deproteinized with each set of samples.
Procedure
Deproteinized samples were planted onto 96-well V-bottomed
plates (Flow Laboratories, McLean, VA, USA) and reagent added.
Assay conditions for the metabolite-specific reactions are outlined
in table 1. All samples were measured in duplicate. Two sets of
sample duplicates were used in the lactose assay; one set was incu-
bated with reagent A minus the -galactosidase to account for the
concentration of free galactose in the plasma.
The final reactions were stopped with the addition of 150 μΐ of
sodium hydroxide (10 mmol/1). Aliquots (5 μΐ) from each well
were transferred to an opaque, white Microlite® 96-well round-
bottomed plate, further diluted with 10 mmol/1 sodium hydroxide
(40 μΐ) and then 15 μΐ of bioluminescent reagent was injected. The
luminometer was programmed for a 5 second delay after addition
of the bioluminescent reagent, followed by a 1 second read period.
The peak and mean light response over the latter period was calcu-
lated. In all cases, the mean light response was used. Samples were
repeated if duplicates differed by more than 10%.
Results
Bioluminescent assay
The 5 second delay period after injection of the biolumi-
nescent reagent was sufficient to ensure that the kinetic
reaction had reached a plateau before the response was
read for a further 1 second. The reaction was not limited
by substrate supply over this period (fig. 1). The detec-
tion limit of the bioluminescent assay, defined as the
lowest concentration of NADH in the reaction well that
was significantly different from the mean (n = 4) light
response of the blanks (at 99% confidence) was 0.5
nmol/1, and the response was linear (r2 = 0.999) to 2.5
μιηο1/1οίΝΑΟΗ(Γ^.2).
Standard curves
The reactions were checked to ensure that they had
reached completion within the incubation time and that
there was no drift reactions due to contaminating en-
zymes or metabolites. To check accuracy, the standards
of -hydroxybutyrate, .D-lactate and lactose were re-
acted, and the change in absorbance at 340 nm checked
against known concentrations of NADH. The light re-
sponse to deproteinized standards increased linearly
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(r2 ̂  0.998) with an increase in the concentration of the
standards up to 1 mmol/1.
Recoveries, imprecision and detection limit
The addition of three spikes of increasing concentration
(25, 50 and 100 μηιοΐ/ΐ) to aliquots of three different
samples of piglet plasma showed complete recovery of
the various metabolites (tab. 2). The metabolites were
stable in plasma for at least 6 months if deproteinized
and stored at —20 °C. The enzyme ZMactate dehydroge-
nase was specific for D-lactate and did not react with
the L-isomer of lactate, although the L-lactate salt
(Boehringer Mannheim, Lot # 11742634-43) was con-




Fig. 1 The light response after injection of bioluminescent rea-
gent (t0) into a well containing NADH. The reagent (15 μΐ) was
injected into a final volume of 60 μΐ containing approximately







Fig. 2 Standard curve for NADH. The concentration of NADH
is given as the final concentration in the luminometer reaction well.
The regression line for concentrations below 2 umol/1 (a) was
y = 0.06 + 3.5x (r2 = 0.999).
more, incubation in 0.6 mol/1 perchloric acid for several
hours at room temperature did not result in the racemiza-
tion of L-lactate into D-lactate.
The within-plate imprecision of the luminometer was
evaluated by transferring aliquots of a NADH solution
to each well of the luminometer plate. The light response
(RLU) was 0.674 ± 0.023 RLU (n = 96, C. V. = 3.3%)
for the plate if the temperature of the machine was set
at 30 °C and the plate was equilibrated for 5 minutes
before being run. The reproducibility of the assays was
checked by including a sample (quality control) of
known concentration on all plates. The quality controls
(mean ± SD) measured 133 ± 8 μηιοΙ/1 (CV = 6%;
η = 9) for ZMactate, 59 ± 3 umoVl (CV = 5%; η = 17)
for lactose and 15 ± 0.6 μηιοΙ/1 (CV = 4%; η = 7) for
-hydroxybutyrate (tab. 2).
The assays had a high sensitivity (tab. 2) although dilu-
tion of the sample at deproteinization resulted in a sub-
stantial decrease in sample sensitivity. Thus, the sample
sensitivity was defined as the lowest concentration in
the undiluted sample that was significantly different (at
99% confidence) from the mean blank response.
Interference studies
Inhibition of the light response by the components of
the metabolite-specific reagents was minimized by the
high dilution of the initial reaction mixture prior to
transfer to the Microlite® plates. The effects of the vari-
ous components on the light response are given in ta-
ble 3.
Metabolite concentrations in piglet plasma
The concentration of lactose in the peripheral plasma of
the piglet peaked at 24 h after birth (211 ±49 μηιοΙ/1)
and decreased thereafter (fig. 3). The concentration of
-hydroxybutytate in the plasma of the newborn piglets
was less than 5 μηιοΙ/1. The concentration increased dur-
ing the first 3 hours to 15 ± 4 μπιοΐ/ΐ and remained rela-
tively stable for the duration of the sampling period
(12 ± 7 μπιοΐ/ΐ). The concentration of D-lactate in the
peripheral plasma of the young piglet was low at birth
(22 ± 2 umol/l) but increased significantly by 72 h, and
continued to increase thereafter, reaching 423 ± 79
μιηοΐ/ΐ at 120 h (fig. 4).
Discussion
The technique described here is substantially simpler
than previous luminometric techniques, and has elimi-
nated the need for the inclusion of internal standards to
account for variation in the kinetic response between
samples and between standards and samples (2).
Furthermore, this technique represents an improvement
in sensitivity and a decrease in the cost of the biolumi-
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Tab. 2 Recovery of known concentrations of spikes added to samples of piglet plasma, the inter-assay
























Mean ± SE n
2.1 ± 0.2 5
2.2 ± 0.2 9
2.4 ± 0.3 17
Assayb (nmol/1)
Mean ± SE n
1.0 ± 0.1 5
0.6 ± 0.05 9
0.7 ± 0.08 17
1 The lowest concentration in (a) the undeproteinized sample and (b) the luminometer reaction well,
that was significantly different from the mean blank (at 99% confidence).
Tab. 3 Concentration of reagent components that result in a slight
(10%) or large (50%) inhibition of the light response to 500
nmol/1 NADH.
Concentration (mmol/l)a

















a The final concentration in the luminometer reaction well (i. e. in
a final volume of 60 μΐ).
b The light response in the absence of the reagent component was
taken as 100%.
c The light response at the concentration normally present in the
diluted reagent (i. e. in a final volume of 60 μΐ) was taken as 100%.
nescent assay, and may be applied to a range of metabo-
lite assays which result in NADH production, with little
modification of these existing assays. In addition, the
assays were developed for micro-samples of plasma
from the piglet (an accessible and cost-effective medical
model). The small volume of plasma required means
that less invasive blood sampling techniques may be
used, such as finger, ear or heel pricks.
The ML2250 Microlite Luminometer reads each well in
a 96-well plate in approximately 19 minutes, which is
considerably faster than previously described methods
(1, 3). The opaque Microlite® plates used for the biolu-
minescent reaction maximized sensitivity and eliminated
cross talk. However, in preliminary experiments it was
found that the initial reactions involving the conversion
of the metabolite and the co-production of NADH, did
not complete in the Microlite® plates. Therefore the ini-
tial reaction(s) was carried out in 96-well V-bottomed
plates. The separation of the metabolite-specific reac-
tion^) from the bioluminescent reaction, allowed a
greater dilution of the sample and reagent, thus decreas-
ing possible interference or inhibition of the biolumines-
cent reactions.
Although sodium hydroxide caused some inhibition of
the light response (tab. 3) the use of sodium hydroxide
as a diluent served several purposes. Addition of the
sodium hydroxide to the metabolite-specific reaction
made the conditions sufficiently alkaline to stop enzy-





Fig. 3 Concentration of galactose and lactose in the plasma of
suckling piglets over the first 120 hours after birth (to). All values




Fig. 4 Concentration of D-lactate in the plasma over the first 120
hours after birth (t0) in suckling piglets. All values given are mean
± SE (n = 11).
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the contribution of any contaminating enzymes (3).
Furthermore, NADH is unstable at high dilution, but sta-
bility can be increased if the NADH in the reaction mix-
ture is in alkaline conditions (12). Ascorbic acid at a con-
centration of 2 mmol/1 or greater, also stabilizes NADH
(12) and was therefore included in the longer initial incu-
bation for Z>-lactate. However, the final concentration of
ascorbic acid in the luminometer well was kept to a mini-
mum to prevent inhibition of the light response.
Evaluation of the methods showed that the precision was
satisfactory and that the recoveries were quantitative.
There was some interference of the kinetic reaction (i. e.
the bioluminescent reactions) by various components of
the assay mixtures, however, these were minimized with
increased dilution before transfer to the Microlite®
plates. Furthermore, inhibition was standard for the plate
and did not involve sample to sample variation. In early
experiments, which were run at room temperature, there
was a significant change in the kinetic response of the
bioluminescent reagent over the plate due to temperature
variations. However, the reaction plate could be main-
tained at a constant (±2 °C) temperature between 30 °C
and 40 °C, which was sufficient to keep the variability
over a plate at acceptable (< 5%) levels.
The bioluminescent assay was coupled to three assays
with possible clinical applications. Measurement of
plasma lactose showed that despite a continuing increase
in the concentration of lactose hi the milk of the sow
over the first 5 days post-partum (13—14), and the high
concentration of galactose in the plasma of the piglets,
there was a decline in the concentration of lactose in the
piglet plasma, after 24 hours. This agrees with previous
reports indicating that 'closure' of the gut of the piglet
to macromolecular uptake occurs at approximately 24 to
36 hours after birth (13 — 14). Thus, this assay may have
clinical applications for the investigation of gut perme-
ability/damage. Furthermore, this assay could be adapted
for the determination of lactulose (17—19), which would
remove variation due to differences hi the hydrolytic ca-
pacity between individuals.
ß-Hydroxybutyrate is the major ketone body circulating
in the blood of healthy individuals (19). During ketosis
the concentration, as well as the proportion of ß-hydro-
xybutyrate increases (20), although the extent of the
increase is variable. The traditional diagnostic spot test
detects acetoacetate and acetone, but does not react with
ß-hydroxybutyrate. Thus, ketosis may be greatly, and
variably, under-estimated. Several methods have been
described for the kinetic measurement of ß-hydroxybu-
tyrate, however, these methods differ considerably with
regards to reaction conditions, and interference from un-
identified causes could invalidate these methods (21).
Coupled to the bioluminescent reaction, the assay de-
scribed here provides an easy, cost effective means for
the identification and investigation of clinical and sub-
clinical ketosis in humans and animals, using only small
samples of plasma.
Acidosis due to £>-lactate is well known in ruminants
after carbohydrate over-feeding (22), and has been de-
scribed in man (23). The presence of D-lactate in body
fluids indicates either bacterial invasion or absorption
from an area of high bacterial activity, such as the gut
(24). In the present study, the timing of the increase in
the concentration of plasma D-lactate agreed with previ-
ous reports indicating colonization of the sterile gut of
the newborn piglet (25). Changes in plasma D-lactate
can also be used to indicate the success of dietary man-
agement of D-lactic acidosis in short bowel syndrome
(26). The assay for D-lactate described in this paper,
provides a sensitive and specific means for monitoring
ZMactate acidosis.
The present bioluminometric method affords several ad-
vantages over earlier methods for metabolite determina-
tion hi plasma samples. An important improvement is
the increased stability of the bioluminescent reagent,
which may be stored frozen for several months. Further-
more, the large dilution of sample prior to reaction with
the bioluminescent reagent has completely removed
sample-inhibition of the luminescence signal, which has
remained a problem with modern luminometric tech-
niques (2).
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